{
  "meta": {
    "title": "Ini_Cet_May_2023",
    "url": "https://brainandscalpel.vercel.app/ini-cet-may-2023-28ae54e9.html",
    "scrapedAt": "2025-11-30T07:36:08.009Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Trofinetide</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Olcegepant</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Lasmiditan</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Erenumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a new drug approved for the treatment of Rett syndrome?</span></p>",
      "unique_key": "DT1323574",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323574,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Rett syndrome is a rare, <strong><em>genetic neuro developmental</em></strong> disorder.</p>\r\n<p><strong><em>Trofinetide</em></strong> is a <strong><em>synthetic analog of glycine-proline-glutamate</em></strong>, the N-terminal tripeptide of the <strong><em>insulin-like growth factor 1 protein</em></strong> and has demonstrated <strong><em>clinical benefit in phase 2 studies in Rett syndrome.</em></strong></p>\r\n<p><strong>Reference:</strong> https://clinicaltrials.gov/study/NCT04181723</p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Mirtazapine</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Trazodone</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Venlafaxine</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Bupropion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was started on a drug for mood disorder, and he developed priapism. The causative drug is:</span></p>",
      "unique_key": "DT1323580",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323580,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Trazodone</strong> It is the <strong><em>first atypical antidepressant</em></strong>; less efficiently <strong><em>blocks 5-HT uptake, but<u>has prominent&nbsp;&alpha;</u></em></strong> <u>-<strong><em>adrenergic</em></strong></u> <strong><em>and weak 5-HT2 antagonistic actions.</em></strong></p>\r\n<p>It is <strong><em>sedative</em></strong> but not anticholinergic, <strong><em>causing bradycardia</em></strong> rather than tachycardia. Nausea is felt, especially in the beginning.</p>\r\n<p><strong><em>Inappropriate, prolonged and painful penile erection (priapism).</em></strong> The <strong><em>&alpha;1 adrenergic blocking property has been held responsible</em></strong> for this effect as well as for <strong><em>postural hypotension. Trazodone used in depression associated with insomnia.</em></strong></p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Halstead</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Salazar</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Matzke</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Rumack</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following graphs is used for vancomycin dosing?</span></p>",
      "unique_key": "DT1323581",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323581,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Matzke Nomogram is used for Vancomycin dose adjustment.</p>\r\n<p>Monitoring of <strong><em>antibiotic plasma concentrations</em></strong> also is important when using an extended- interval dosing regimen. For routine monitoring of extended-interval dosing, <strong><em>a single random concentration obtained 6 to 14 h after the start of the infusion</em></strong> can be obtained and <strong><em>plotted against a standard nomogram to determine if dosage adjustment is required.</em></strong></p>\r\n<p>However, <strong><em>the most accurate method for monitoring plasma levels for dose adjustment is to measure the concentration in two plasma samples drawn several hours apart (e.g., at 2 and 12 h after a dose).</em></strong> The clearance then can be calculated and the dose adjusted to achieve the desired target range.</p>\r\n<p>Rumack Mathew nomogram is used for Paracetamol dose adjustment.</p>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">T790M mutation</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">L858R mutation</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">T890M mutation</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">m790T mutation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Osimertinib is used in the NSCLC with mutation due to?</span></p>",
      "unique_key": "DT1323582",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323582,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><em>Osimertinib is a third-generation, orally bioavailable, irreversible inhibitor of <u>T790M-mutant EGFR</u></em></strong></p>\r\n<p><strong><em>Osimertinib is also a very potent inhibitor of the EGFR mutants that are sensitive to first- and second-generation EGFR inhibitors.</em></strong> The T790M gatekeeper mutation in Exon 20 is often acquired after prior treatment with other EGFR kinase inhibitors.</p>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Nivolumab is used in NSCLC</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Nivolumab plus chemotherapy used in NSCLC</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Pembrolizumab used in NSCLC</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Pembrolizumab plus chemotherapy used in NSCLC</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is true about the keynote 189 trial?</span></p>",
      "unique_key": "DT1323583",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323583,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Keynote 189 trial is a famous trial on chemotherapy in patients of NSCLC using Pembrolizumab and Platinum based chemotherapy.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250421529ac92d-f64c-4bbb-bc05-0e586540de96.jpg\">",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Lapatinib</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Vismodegib</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Vemurafenib</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Erlotinib</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Drug used for trastuzumab resistant Her-2 positive breast cancer?</span></p>",
      "unique_key": "DT1323584",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323584,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><u>Lapatinib</u></strong></p>\r\n<p>This is a <strong><em>synthetic orally active inhibitor of EGFR/HER2</em></strong> which penetrates cells and blocks tyrosine kinase activity of the liganded HER2 and thus interferes with signal transduction.</p>\r\n<p><strong><em>Lapatinib is indicated in metastatic HER2 positive breast cancer that is nonresponsive to trastuzumab and is used in combination with capecitabine.</em></strong></p>\r\n<p>Adverse effects are fatigue, abdominal pain, diarrhoea, decreased LVEF, heart failure and Q-T prolongation. However, <strong><em>lapatinib is considered to be less cardiotoxic than trastuzumab.</em></strong></p>\r\n<p><strong><em>Option B: Vismodegib is a SHH(sonic hedgehog) protein inhibitor</em></strong></p>\r\n<p><strong><em>Option C: Vemurafenib is a BRAF V600E inhibitor</em></strong></p>\r\n<p><strong><em>Option D: Erlotinib is a tyrosine kinase inhibitor</em></strong></p>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Canagliflozin</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Acarbose</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Linagliptin</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Liraglutide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A diabetic patient was started on a drug that decreased HbA1C from 7.6 to 6.8. She started complaining of itching around the vulvovaginal area. Which drug was she started on?</span></p>",
      "unique_key": "DT1323585",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323585,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>This is a case of vulvovaginal candidiasis, a side effect of using SGLT2 inhibitors.</p>\r\n<p><strong>Dapagliflozin, Canagliflozin</strong></p>\r\n<p>These SGLT-2 inhibitors are approved for use in <strong><em>type 2 DM patients</em></strong>. After once daily dosing, they produce <strong><em>round-the-clock glucosuria and lower blood glucose levels.</em></strong></p>\r\n<p>Used alone or in combination with other antidiabetic drugs, they <strong><em>reduce HbA1C levels by 0.5-1.0%,</em></strong> but do not cause hypoglycemia.</p>\r\n<p>The concerns which appear inbuilt due to their mechanism of action are-<strong><em>glycosuria which can predispose to urinary and genital infections, electrolyte imbalance, ketoacidosis and increased urinary frequency</em></strong>.</p>\r\n<p>They are <strong><em>contraindicated in patients with renal insufficiency.</em></strong></p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Approved for absence seizure</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">It is not absorbed in the stomach</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">It can cause fine tremors in therapeutic range</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">It is not teratogenic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true regarding lithium?</span></p>",
      "unique_key": "DT1323586",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323586,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><u>Adverse effects of Lithium</u></strong></p>\r\n<ul>\r\n<li><strong><em>Nausea, vomiting and mild diarrhoea</em></strong></li>\r\n<li><strong><em>Thirst and polyuria</em></strong></li>\r\n<li><strong><em>Fine tremors may occur even at therapeutic concentrations</em></strong>.</li>\r\n<li><strong><em>CNS toxicity</em></strong> manifests as <u>plasma concentration rises</u> producing <strong><em>coarse tremors, giddiness, ataxia, motor incoordination, nystagmus, mental confusion, slurred speech, hyperreflexia</em></strong></li>\r\n</ul>\r\n<p><strong><em>Option A: Ethosuximide and Valproate are approved for Absence seizures, no Lithium</em></strong></p>\r\n<p><strong><em>Option B: Lithium is administered via oral route and hence is absorbed via stomach</em></strong></p>\r\n<p><strong><em>Option D: Lithium is teratogenic and causes Ebstein's Anomaly if taken in pregnancy</em></strong></p>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Burkholderia cepacia</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Acinetobacter</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudomonas</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Stenotrophomonas</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A microorganism resistant to meropenem and aminoglycosides but sensitive to piperacillin clavulanate, cotrimoxazole? The causative organism is</span></p>",
      "unique_key": "DT1323587",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323587,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><u>S. maltophilia Infections</u></strong></p>\r\n<p><strong><em>The intrinsic resistance of S. maltophilia</em></strong> to most antibiotics renders infection difficult to treat.</p>\r\n<p>The antibiotics to which it is <strong><em>most often susceptible are TMP-SMX, ticarcillin/clavulanate, levofloxacin, and tigecycline</em></strong>.</p>\r\n<p>Consequently, a <strong><em>combination of TMP-SMX and ticarcillin/clavulanate is recommended for initial therapy</em></strong> pending susceptibility testing.</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcitonin</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Vasopressin</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Aldosterone</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Leptin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following acts via the JAK-STAT pathway?</span></p>",
      "unique_key": "DT1323588",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323588,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><em>Janus kinases (JAKs)</em></strong> are non-receptor tyrosine kinases involved in cytokine receptor signalling. Their interaction with <strong><em>STATs</em></strong> (signal transducers and activators of transcription) <strong><em>leads to activation of the transcription of genes involved in many vital events, such as inflammation, hematopoiesis, wound repair, and apoptosis</em></strong>, among others.</p>\r\n<p>As a consequence, <strong><em>inhibition of this pathway offers current and potential treatments for myriad diseases</em></strong>, including dermatological conditions.</p>\r\n<p>Dozens of <strong><em>growth factors and cytokines, including ILs, IFNs, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), erythropoietin, growth hormone, and <u>leptin</u>, interact with membrane receptors and initiate signaling via the JAK-STAT signaling pathway.</em></strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong><em>List of hormones acting via secondary messengers:</em></strong></p>\r\n<ol>\r\n<li><strong><em>G-protein coupled receptors(GPCR):</em></strong>\r\n<ul>\r\n<li><strong><em>Gs: ACTH, CRH, TSH, GnRH, FSH, LH, Hcg, Vasopressin(V2), Catecholamines(beta receptors), Glucagon, Parathormone</em></strong></li>\r\n<li><strong><em>Gi: Catecholamines(alpha 2 receptors), Acetylcholine(M2, M4 receptors), Somatostatin</em></strong></li>\r\n<li><strong><em>Gq: Vasopressin(V1), Catecholamines(alpha 1 receptors), Gastrin, CCK, Oxytocin, Acetylcholine(M1,M3,M5)</em></strong></li>\r\n<li><strong><em>Cgmp: ANP, NO</em></strong></li>\r\n</ul>\r\n</li>\r\n<li><strong><em>Tyrosine Kinase receptors:</em></strong>\r\n<ul>\r\n<li><strong><em>MAP Kinase: IGF, VEGF, EGF, FGF, PDGF</em></strong></li>\r\n<li><strong><em>JAK STAT: Growth hormone, Erythropoietin, Insulin, Prolactin</em></strong></li>\r\n</ul>\r\n</li>\r\n</ol>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}